Amid Biotech Pitfalls, This Stock Has Outperformed Nvidia in the Last 3 Months
Biotech stocks, especially of smaller companies, are notoriously risky investment exposures. Because their bread and butter is drug development, its complexity cannot be easily accounted for. Although the Center for Drug Evaluation and Research (CDER) …